TPST
https://www.otcmarkets.com/stock/TPST/security
https://www.quotemedia.com/portal/history?qm_symbol=TPST
https://stockinvest.us/stock/TPST
http://www.stockta.com/cgi-bin/analysis.pl?symb=TPST&cobrand=&mode=stock
https://www.stockscores.com/charts/charts/?ticker=TPST
https://www.barchart.com/stocks/quotes/TPST/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(50);SMA(100);SMA(20);SMA(200);RSI(14,100);MFI(14,100);SMACD(12,26,9);PTP(50);PTP(50);BOLLW(20,2);BBANDS(20,2)&sym=TPST&grid=1&height=500&studyheight=100
https://www.barchart.com/stocks/quotes/TPST/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(50);SMA(100);SMA(20);SMA(200);RSI(14,100);MFI(14,100);SMACD(12,26,9);PTP(50);PTP(50);BOLLW(20,2);BBANDS(20,2)&sym=TPST&grid=1&height=500&studyheight=100
________________________________________________________
Subject: Shareholders Rights Plan
Oct. 11, 2023
Tempest
Adopts Limited Duration
Stockholder Rights Plan
Unfortunately,
Tempest, like many other biotechnology companies,
continues to experience a significant and ongoing
dislocation in the trading price of its common stock.
https://www.otcmarkets.com/stock/TPST/news/story?e&id=2654484
_____________________________________________________
The Secrets Behind a 4000% Biotech Stock Surge
https://www.barchart.com/story/news/21211107/the-secrets-behind-a-4000-biotech-stock-surge
______________________________________________________
Factors that Helped the Stock Surge
When it comes to small-cap stocks,
or in this case, micro-cap and low-float stock,
several factors lend a helping hand to a stock surge.
While the market capitalization of TPST
was over $100 million at one point,
as the stock rocketed 4000% higher,
the stock had a modest market cap
of about $5 million before the move.
This micro-cap starting point
had positioned the stock
to achieve significant percent returns
should volume and a catalyst
enter the frame.
The biggest contributing factor
to the enormous surge was
the stock float size
relative to the volume traded.
The stock is estimated to have
a public float of 12.5 million shares,
having grown post-dilution.
On day one of the breakout in volume and price,
the stock traded over 170 million shares.
This influx in volume
created an enormous supply and demand imbalance,
as the float was likely significantly smaller
than 12.5 million shares at that point.
So, with a lack of supply and a surge in demand,
it appeared the stock had nowhere to go
but higher on the day.
The final leading factor
that contributed to the surge higher
is intraday shorts.
Intraday shorts threw gasoline on the fire.
The supply and demand imbalance existed
even without the involvement of short sellers.
However, with a wide availability of locates reported for TPST
at a reasonably low price, $0.17
retail short sellers
contributed significantly to the imbalance,
resulting in a remarkable squeeze higher.
__________________________________________________________
Embedded Chart
Embedded Chart
_________________________________________________________
Live! Charts
Recent TPST News
- Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/07/2024 08:30:00 AM
- Tempest to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/21/2024 12:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/13/2024 08:54:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:29:58 PM
- Tempest Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 08:29:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:25:05 PM
- Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/26/2024 08:05:17 PM
- Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting • GlobeNewswire Inc. • 04/09/2024 12:00:00 PM
- Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications • GlobeNewswire Inc. • 04/04/2024 12:00:00 PM
- Tempest Reports Year End 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/19/2024 08:25:36 PM
- Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
- Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Tempest to Present at the 44th Annual TD Cowen Healthcare Conference • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:49:42 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:12:13 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/08/2024 10:41:56 PM
- Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/02/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:41:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:40:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:39:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:38:19 PM
- Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/05/2024 09:05:00 PM
- Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/01/2023 09:15:51 PM
- Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference • GlobeNewswire Inc. • 11/20/2023 01:00:00 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 11/17/2023 09:46:27 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM